Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAurora Uk Alpha Regulatory News (ARR)

Share Price Information for Aurora Uk Alpha (ARR)

Share Price is delayed by 15 minutes
Get Live Data
239.00    -0.50 (-0.21%)
Bid:
239.00
Ask:
241.00
Spread: 2.00 (0.837%)
Market Cap: £259.24m
ARR Live PriceLast checked at - London Stock Exchange

Intraday Aurora Uk Alpha Share Chart

Share Buyback

11 Feb 2025 07:00

RNS Number : 5918W
Aurora UK Alpha PLC
11 February 2025
 

11 February 2025

 

Aurora UK Alpha plc

LEI: 2138007OUWIZFMAGO575

 

Share Buyback

 

The Board of Aurora UK Alpha plc (the "Company") announces the commencement of a discretionary share buyback programme (the "Share Buyback"), conducted in accordance with existing authorities.

 

The Board regularly reviews market conditions and believes that a buyback programme currently offers an attractive use of capital.

 

Share repurchases, if implemented, will be conducted in open market transactions and may be made from time to time depending on market conditions, share price, and trading volume. There is no certainty that any buybacks will be completed and may be paused or discontinued at any time.

 

The Share Buyback will take place within the limitations of the authority granted to the Board of the Company at its annual general meeting ("General Authority"), held on 12 June 2024, pursuant to which the maximum number of shares which may be bought back is 11,436,279. 

 

About the Share Buyback

 

· The Share Buyback will be financed through the Company's cash resources.

· The purchased Ordinary Shares will be held by the Company in treasury at the Company's discretion for later reissue or cancellation.

· The Company confirms that it is not in a closed period and currently has no unpublished inside information.

· The aggregate number of Ordinary Shares acquired by the Company pursuant to the Share Buyback shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the General Authority.

· The potential purchase of shares will commence on the date of this announcement and will continue until the earlier of the expiration of the General Authority or until the number of Ordinary Shares equal to the maximum pecuniary amount have been purchased under the Share Buyback or the process is terminated or paused.

· Share repurchases, if undertaken, will be conducted at prevailing market prices, subject to a maximum price per share determined in accordance with the General Authority (being no more than 105% of the average middle market closing price over the preceding five business days, and a minimum price of 25 pence per share.

· The Company does not intend to rely on the safe harbour provisions dealing with trading for share buyback programmes set out in Article 5 of the Market Abuse Regulation 596/2014/EU (as onshored into UK legislation following Brexit).

 

As at 11 February 2025, the Company's total issued share capital consisted of 114,572,742 Ordinary Shares, with one voting right per share. The Company does not as at this date hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company was 114,572,742.

 

This announcement contains inside information for the purposes of Article 7 of Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended, and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person responsible for arranging for the release of this announcement on behalf of Aurora Investment Trust plc is Frostrow Capital LLP, the Company Secretary.

 

 

Frostrow Capital LLP

Company Secretary

Tel: 020 3709 8733

 

Panmure Liberum Limited

Chris Clarke / Ashwin Kohli

Tel: 020 3100 2000

LEI: 2138007OUWIZFMAGO575

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSFWFASEISEIE
Date   Source Headline
4th Jun 20262:08 pmRNSNet Asset Value(s)
3rd Jun 20264:58 pmRNSMonthly Fact Sheet as at 31 May 2026
3rd Jun 20264:55 pmRNSTransaction in Own Shares
3rd Jun 20263:49 pmRNSNet Asset Value(s)
2nd Jun 202611:55 amRNSNet Asset Value(s)
1st Jun 20265:20 pmRNSTransaction in Own Shares
1st Jun 202612:19 pmRNSNet Asset Value(s)
1st Jun 202611:19 amRNSTotal Voting Rights
29th May 20265:12 pmRNSTransaction in Own Shares
29th May 20261:45 pmRNSNet Asset Value(s)
28th May 20265:29 pmRNSTransaction in Own Shares
28th May 202612:11 pmRNSNet Asset Value(s)
27th May 20265:01 pmRNSTransaction in Own Shares
27th May 202612:43 pmRNSNet Asset Value(s)
26th May 20265:12 pmRNSTransaction in Own Shares
26th May 202612:29 pmRNSNet Asset Value(s)
26th May 202610:15 amRNSDirector Declaration
22nd May 20265:11 pmRNSTransaction in Own Shares
22nd May 202612:59 pmRNSNet Asset Value(s)
22nd May 202611:57 amRNSInterim Dividend in place of Final Dividend
21st May 20265:01 pmRNSNet Asset Value(s)
21st May 20261:24 pmRNSNet Asset Value(s)
20th May 20265:14 pmRNSTransaction in Own Shares
20th May 20262:07 pmRNSNet Asset Value(s)
19th May 20265:24 pmRNSTransaction in Own Shares
19th May 202612:56 pmRNSNet Asset Value(s)
18th May 20265:07 pmRNSTransaction in Own Shares
18th May 202612:14 pmRNSNet Asset Value(s)
15th May 20262:48 pmRNSNet Asset Value(s)
14th May 20265:22 pmRNSTransaction in Own Shares
14th May 202612:49 pmRNSNet Asset Value(s)
13th May 20265:12 pmRNSTransaction in Own Shares
13th May 20262:31 pmRNSNet Asset Value(s)
12th May 202612:46 pmRNSNet Asset Value(s)
11th May 20265:09 pmRNSTransaction in Own Shares
11th May 20261:16 pmRNSNet Asset Value(s)
8th May 20265:15 pmRNSTransaction in Own Shares
8th May 202612:44 pmRNSNet Asset Value(s)
7th May 20264:53 pmRNSTransaction in Own Shares
7th May 202612:04 pmRNSNet Asset Value(s)
6th May 20265:01 pmRNSMonthly Fact Sheet as at 30 April 2026
6th May 20264:55 pmRNSTransaction in Own Shares
6th May 20262:14 pmRNSNet Asset Value(s)
5th May 202612:14 pmRNSNet Asset Value(s)
1st May 20262:16 pmRNSNet Asset Value(s)
1st May 20269:53 amRNSTotal Voting Rights
30th Apr 20264:07 pmRNSCorrection Holding(s) in Company
30th Apr 20262:37 pmRNSNet Asset Value(s)
29th Apr 20265:00 pmRNSTransaction in Own Shares
29th Apr 20262:13 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.